Zhang J - Search Results

1

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer.

Zhou S, Ren S, Yan L, Zhang L, Tang L, Zhang J, Zhou C. Zhou S, et al. Among authors: zhang l, zhang j. Respirology. 2009 Jul;14(5):709-15. doi: 10.1111/j.1440-1843.2009.01564.x. Respirology. 2009. PMID: 19659649 Clinical Trial.

2

[Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].

Zhou CC, Zhang J, Zheng D, Lu MJ, Lu B, Xu JF. Zhou CC, et al. Among authors: zhang j. Zhonghua Jie He He Hu Xi Za Zhi. 2004 Aug;27(8):546-8. Zhonghua Jie He He Hu Xi Za Zhi. 2004. PMID: 15388005 Clinical Trial. Chinese.

3

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J. Zhou C, et al. Among authors: zhang l, zhang z, zhang j. Jpn J Clin Oncol. 2010 Oct;40(10):954-60. doi: 10.1093/jjco/hyq071. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462983

4

ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.

Su C, Zhou S, Zhang L, Ren S, Xu J, Zhang J, Lv M, Zhang J, Zhou C. Su C, et al. Among authors: zhang l, zhang j. Med Oncol. 2011 Dec;28(4):1411-7. doi: 10.1007/s12032-010-9553-9. Epub 2010 May 14. Med Oncol. 2011. PMID: 20467918

5

High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

Ren S, Zhou S, Zhang L, Xu J, Lv M, Zhang J, Zhou C, Zhang J. Ren S, et al. Among authors: zhang l, zhang j. Cancer Invest. 2010 Dec;28(10):1078-83. doi: 10.3109/07357901003735659. Epub 2010 May 26. Cancer Invest. 2010. PMID: 20504223 Clinical Trial.

6

[Relationship between mutations of epidermal growth factor receptor in the plasma and pleural effusion and responses to gefitinib in advanced pretreated non-small cell lung cancer].

Guo J, Zhou C, Zhang J, Tang L. Guo J, et al. Among authors: zhang j. Zhongguo Fei Ai Za Zhi. 2007 Dec 20;10(6):504-7. doi: 10.3779/j.issn.1009-3419.2007.06.12. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21129309 Free article. Chinese.

7

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, Xu J, Lv M, Zhang J, Zhou C. Ren S, et al. Among authors: zhang l, zhang j. Lung Cancer. 2012 Jan;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023. Epub 2011 Jun 14. Lung Cancer. 2012. PMID: 21676483

8

[Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer].

Zhang ZL, Zhou CC, Zhang J, Tang L, Su B. Zhang ZL, et al. Among authors: zhang j. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Dec;30(12):936-40. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 18336773 Chinese.

9

[Relationship between single nucleotide polymorphism of the equilibrative nucleoside transporter ENT3 and susceptibility to lung cancer].

Li X, Zhang J, Zhang Z, Zhou C. Li X, et al. Among authors: zhang j, zhang z. Zhongguo Fei Ai Za Zhi. 2010 May;13(5):458-63. doi: 10.3779/j.issn.1009-3419.2010.05.15. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20677642 Free PMC article. Chinese.

10

[Relationship between polymorphisms of DNA repair gene ERCC1 and susceptibility to lung cancer.].

Zhang Z, Zhou C, Zhang J, Tang L, Su B. Zhang Z, et al. Among authors: zhang j. Zhongguo Fei Ai Za Zhi. 2008 Apr 20;11(2):183-8. doi: 10.3779/j.issn.1009-3419.2008.02.022. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731898 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178,359 results

Search Page

Filters